Regulating fragile X gene transcription in the brain and beyond
Open Access
- 1 November 2005
- journal article
- review article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 205 (2) , 170-175
- https://doi.org/10.1002/jcp.20401
Abstract
The past several years have seen remarkable growth in our understanding of the molecular processes underlying fragile X syndrome (FXS). Many studies have provided new insights into the regulation of Fmr1 gene expression and the potential function of its protein product. It is now known that the promoter elements modulating Fmr1 transcription involve a complex array of both cis and trans factors. Moreover, recent studies of epigenetic modification of chromatin have provided novel clues to unlocking the mysteries behind the regulation of Fmr1 expression. Here, we review the latest findings on the regulation of Fmr1 transcription.Keywords
This publication has 75 references indexed in Scilit:
- RNA and microRNAs in fragile X mental retardationNature Cell Biology, 2004
- c-Jun and Sp1 family are critical for retinoic acid induction of the lamin A/C retinoic acid-responsive elementBiochemical and Biophysical Research Communications, 2004
- Epigenetic programming by maternal behaviorNature Neuroscience, 2004
- Epigenetics in human disease and prospects for epigenetic therapyNature, 2004
- A fragile balance: FMR1 expression levelsHuman Molecular Genetics, 2003
- X chromosome inactivation: how human are mice?Cytogenetic and Genome Research, 2002
- DNA methylation patterns and epigenetic memoryGenes & Development, 2002
- Regulation of the Mouse Cartilage-derived Retinoic Acid-sensitive Protein Gene by the Transcription Factor AP-2Published by Elsevier ,1998
- AP-2 Gene Expression and Modulation by Retinoic Acid during Keratinocyte DifferentiationBiochemical and Biophysical Research Communications, 1996
- Tissue specific expression of FMR–1 provides evidence for a functional role in fragile X syndromeNature Genetics, 1993